Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes

Christian Delles1, Markus P Schneider, Sebastian Oehmer

  • 1Department of Medicine IV/4, University of Erlangen-Nürnberg, Krankenhausstr. 12, D-91054 Erlangen, Germany.

Abstract

Insights

Oxidative stress contributes to kidney vascular dysfunction in type 2 diabetes. Antioxidant vitamin C improved renal blood flow in diabetic patients, suggesting increased reactive oxygen species formation.

Area of Science:

  • Cardiovascular Research
  • Nephrology
  • Diabetes Mellitus Research

Background:

  • Endothelial dysfunction is linked to reactive oxygen species.
  • The role of oxidative stress in type 2 diabetes renal vascular dysfunction is unclear.

Purpose of the Study:

  • To investigate the contribution of oxidative stress to renal vascular endothelial dysfunction in type 2 diabetes.
  • To assess renal haemodynamics in response to nitric oxide synthase inhibition and antioxidant therapy.

Main Methods:

  • Studied 20 type 2 diabetic and 20 non-diabetic hypertensive patients.
  • Infused nitric oxide synthase inhibitor (L-NMMA), L-arginine, and vitamin C with L-arginine.
  • Measured renal haemodynamics, including renal plasma flow (RPF).

Main Results:

  • No difference in RPF response to L-NMMA or L-arginine between groups.
  • Vitamin C plus L-arginine significantly increased RPF more in diabetic patients than non-diabetic patients.
  • This suggests improved nitric oxide bioavailability with antioxidant therapy in type 2 diabetes.

Conclusions:

  • Increased reactive oxygen species formation reduces nitric oxide bioavailability in the renal vasculature of type 2 diabetes patients.
  • Antioxidant intervention highlights the role of oxidative stress in diabetic renal vascular dysfunction.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...